The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer
Abstract
The expression of fatty acid synthase (FAS), a key lipogenic enzyme and potential target for antineoplastic therapy, was analyzed in 87 frozen needle biopsies of prostate cancer using a highly sensitive immunohistochemical detection technique (Envision). In comparison to normal or benign, hyperplastic glandular structures, which were all negative for FAS staining, immunohistochemical signal was evident in 24/25 low grade prostatic epithelial neoplasia (PIN) lesions, in 26/26 high grade PIN lesions and in 82/87 invasive carcinomas. Staining intensity tended to increase from low grade to high grade PIN to invasive carcinoma. Cancers with a high FAS expression had an overall high proliferative index. No correlation was found between FAS expression and lipid accumulation. These findings indicate that increased FAS expression is one of the earliest and most common events in the development of prostate cancer, suggesting that FAS may be used as a general prostate cancer marker and that antineoplastic therapy based on FAS inhibition may be an option for chemoprevention or curative treatment for nearly all prostate cancers. © 2001 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fatty acid synthesis: a potential selective target for antineoplastic therapy
Kuhajda, F. P., Jenner, K., Wood, F. D., Hennigar, R. A., Jacobs, L. B., Dick, J. D., & Pasternack, G. R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6379 · Cited by 705 · cited 1×
“II 5 (6) 10 (11) 0 (0) 0 (0) III 0 (0) 0 (0) 43 (50) 15 (17) IV 0 (0) 0 (0) 0 (0) 12 (14) V 0 (0) 0 (0) 0 (0) 2 (2)”
Alo, P. L., Visca, P., Marci, A., Mangoni, A., Botti, C., & Di Tondo, U. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960201)77:3<474::aid-cncr8>3.0.co;2-k · Cited by 313
Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells.
Pizer, E. S., Jackisch, C., Wood, F. D., Pasternack, G. R., Davidson, N. E., & Kuhajda, F. P. (1996) · PubMed · Cited by 291
Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival
Gansler, T. S., Hardman, W., Hunt, D. A., Schaffel, S., & Hennigar, R. A. (1997) · Human Pathology · doi:10.1016/s0046-8177(97)90177-5 · Cited by 287
Pizer, E. S., Wood, F. D., Heine, H. S., Romantsev, F. E., Pasternack, G. R., & Kuhajda, F. P. (1996) · PubMed · Cited by 277
Swinnen, J. V., Ulrix, W., Heyns, W., & Verhoeven, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.12975 · Cited by 262
Self-citationPizer, E. S., Chrest, F. J., DiGiuseppe, J. A., & Han, W. F. (1998) · PubMed · Cited by 250
Selective activation of the fatty acid synthesis pathway in human prostate cancer
Swinnen, J. V., Vanderhoydonc, F., Elgamal, A. A., Eelen, M., Vercaeren, I., Joniau, S., Van Poppel, H., Baert, L., Goossens, K., Heyns, W., et al. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20001015)88:2<176::aid-ijc5>3.0.co;2-3 · Cited by 245
Self-citationAndrogens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP.
Swinnen, J. V., Esquenet, M., Goossens, K., Heyns, W., & Verhoeven, G. (1997) · PubMed · Cited by 225
Self-citationEpstein, J. I., Carmichael, M., & Partin, A. W. (1995) · Urology · doi:10.1016/s0090-4295(95)96904-7 · Cited by 214
Cited by
Chemistry and Biological Activities of Flavonoids: An Overview
Kumar, S., & Pandey, A. K. (2013) · The Scientific World Journal · doi:10.1155/2013/162750 · Cited by 4,980
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941
Schug, Z. T., Peck, B., Jones, D. T., Zhang, Q., Grosskurth, S., Alam, I. S., Goodwin, L. M., Smethurst, E., Mason, S., Blyth, K., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2014.12.002 · Cited by 820
Lipid metabolism in cancer: New perspectives and emerging mechanisms
Broadfield, L. A., Pane, A. A., Talebi, A., Swinnen, J. V., & Fendt, S.-M. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.04.013 · Cited by 758
Self-citationLipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention
Butler, L. M., Perone, Y., Dehairs, J., Lupien, L. E., de Laat, V., Talebi, A., Loda, M., Kinlaw, W. B., & Swinnen, J. V. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.013 · Cited by 589
Self-citationThe emerging role and targetability of the TCA cycle in cancer metabolism
Anderson, N. M., Mucka, P., Kern, J. G., & Feng, H. (2018) · Protein & Cell · doi:10.1007/s13238-017-0451-1 · Cited by 556
Hilvo, M., Denkert, C., Lehtinen, L., Müller, B., Brockmöller, S., Seppänen-Laakso, T., Budczies, J., Bucher, E., Yetukuri, L., Castillo, S., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3894 · Cited by 532
Brusselmans, K., Vrolix, R., Verhoeven, G., & Swinnen, J. V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408177200 · Cited by 474
Self-citationPathological and molecular aspects of prostate cancer
DeMarzo, A. M., Nelson, W. G., Isaacs, W. B., & Epstein, J. I. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12779-1 · Cited by 472
Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer
Liu, Y. (2006) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500879 · Cited by 433
Furuta, E., Pai, S. K., Zhan, R., Bandyopadhyay, S., Watabe, M., Mo, Y.-Y., Hirota, S., Hosobe, S., Tsukada, T., Miura, K., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2489 · Cited by 392
Acetyl-CoA Carboxylase α Is Essential to Breast Cancer Cell Survival
Chajès, V., Cambot, M., Moreau, K., Lenoir, G. M., & Joulin, V. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1489 · Cited by 347
Positron emission tomography for prostate, bladder, and renal cancer
Schöder, H., & Larson, S. M. (2004) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2004.06.004 · Cited by 337
Beckers, A., Organe, S., Timmermans, L., Scheys, K., Peeters, A., Brusselmans, K., Verhoeven, G., & Swinnen, J. V. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0389 · Cited by 314
Self-citationZhang, D., Tai, L. K., Wong, L. L., Chiu, L.-L., Sethi, S. K., & Koay, E. S. C. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m400221-mcp200 · Cited by 312
11C-acetate PET imaging in prostate cancer
Morris, M. J., & Scher, H. I. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0281-5 · Cited by 294
An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer
Chen, M., Zhang, J., Sampieri, K., Clohessy, J. G., Mendez, L., Gonzalez-Billalabeitia, E., Liu, X.-S., Lee, Y.-R., Fung, J., Katon, J. M., et al. (2018) · Nature Genetics · doi:10.1038/s41588-017-0027-2 · Cited by 293
Fatty acid synthase: A metabolic oncogene in prostate cancer?
Baron, A., Migita, T., Tang, D., & Loda, M. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10708 · Cited by 292
The fat side of prostate cancer
Zadra, G., Photopoulos, C., & Loda, M. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.03.010 · Cited by 291
Metabolic genes in cancer: Their roles in tumor progression and clinical implications
Furuta, E., Okuda, H., Kobayashi, A., & Watabe, K. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.01.005 · Cited by 282
Brusselmans, K., De Schrijver, E., Verhoeven, G., & Swinnen, J. V. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0571 · Cited by 277
Self-citationAnjum, K., Shagufta, B. I., Abbas, S. Q., Patel, S., Khan, I., Shah, S. A. A., Akhter, N., & Hassan, S. S. U. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.05.125 · Cited by 271
RetractedSwinnen, J. V., Van Veldhoven, P. P., Timmermans, L., De Schrijver, E., Brusselmans, K., Vanderhoydonc, F., Van de Sande, T., Heemers, H., Heyns, W., & Verhoeven, G. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00265-1 · Cited by 259
Self-citationLin, H.-P., Cheng, Z.-L., He, R.-Y., Song, L., Tian, M.-X., Zhou, L.-S., Groh, B. S., Liu, W.-R., Ji, M.-B., Ding, C., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1597 · Cited by 150
Metadata
- Authors
- Swinnen, J. V., Roskams, T., Joniau, S., Van Poppel, H., Oyen, R., Baert, L., Heyns, W., & Verhoeven, G.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2001-11-29
- Volume
- 98
- Issue
- 1
- Pages
- 19-22
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2032691440
- Cited by
- 381
- References
- 20
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.